Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy - Recruitment Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy - Recruitment Rhythm (SANTE RR)
This study has been completed.
Sponsor:
MedtronicNeuro
Information provided by (Responsible Party):
MedtronicNeuro
ClinicalTrials.gov Identifier:
NCT00772421
First received: October 14, 2008
Last updated: January 27, 2012
Last verified: January 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The primary objective is to demonstrate that a higher proportion of responders to deep brain stimulation (DBS) in the anterior nucleus (AN) of the thalamus in refractory epilepsy patients in the SANTE study exhibit a recruitment rhythm relative to non-responders.
| Condition | Intervention |
|---|---|
|
Epilepsy |
Device: There was no intervention. |
| Study Type: | Observational |
| Study Design: | Time Perspective: Cross-Sectional |
| Official Title: | Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy - Recruitment Rhythm (SANTE RR) |
Resource links provided by NLM:
Genetics Home Reference related topics:
pyridoxal 5'-phosphate-dependent epilepsy
MedlinePlus related topics:
Epilepsy
U.S. FDA Resources
Further study details as provided by MedtronicNeuro:
Primary Outcome Measures:
- To demonstrate that a higher proportion of DBS responders exhibit a RR relative to non-responders, using maximum tolerated voltage settings, at activated electrode contacts used for DBS stimulation in the SANTE study. [ Time Frame: Study testing to occur during the long-term follow-up phase of the SANTE trial. ] [ Designated as safety issue: Yes ]
Secondary Outcome Measures:
- For patients without a RR at their activated DBS electrode contacts used in the SANTE study, demonstrate that activating other electrode contacts generates a RR. [ Time Frame: Study testing to occur during the long-term follow-up phase of the SANTE trial. ] [ Designated as safety issue: Yes ]
| Enrollment: | 29 |
| Study Start Date: | January 2009 |
| Study Completion Date: | May 2010 |
| Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Responder
A subject having at least a 50% reduction in total seizure frequency compared to the SANTE study 3-month Baseline Phase
|
Device: There was no intervention.
There was no intervention. This study was designed as an in-clinic testing protocol to identify recruitment rhythms.
|
|
Non-responder
A subject with a less than 50% reduction in total seizure frequency compared to the SANTE study 3-month Baseline Phase.
|
Device: There was no intervention.
There was no intervention. This study was designed as an in-clinic testing protocol to identify recruitment rhythms.
|
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
The study will enroll the number of patients necessary to achieve the required sample size of 18 responders and 18 non-responders at a minimum of six (6) centers participating in the U.S. SANTE study.
Criteria
Inclusion Criteria:
- Enrolled in the SANTÉ study, have been implanted with a complete DBS system, and is currently receiving stimulation in the long-term follow-up phase (post Month 13) of the study
- Patient or legal representative is able to understand and provide signed consent for participating in the study
- Willing and available to attend the visit as scheduled and to comply with the study protocol
Exclusion Criteria:
- Patients unable to tolerate stimulation turned OFF during the testing period
- Are pregnant or suspected of being pregnant
Contacts and Locations
No Contacts or Locations Provided
More Information
No publications provided
| Responsible Party: | MedtronicNeuro |
| ClinicalTrials.gov Identifier: | NCT00772421 History of Changes |
| Other Study ID Numbers: | 1636 |
| Study First Received: | October 14, 2008 |
| Last Updated: | January 27, 2012 |
| Health Authority: | United States: Food and Drug Administration |
Keywords provided by MedtronicNeuro:
|
Epilepsy Recruitment rhythm DBS |
Additional relevant MeSH terms:
|
Epilepsy Brain Diseases Central Nervous System Diseases Nervous System Diseases |
ClinicalTrials.gov processed this record on May 19, 2013